ArticleBMC cardiovascular disorders2026
Association of naples prognostic score and systemic immune-inflammation index with left ventricular recovery in peripartum cardiomyopathy.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeripartum cardiomyopathy (PPCM) is a life-threatening form of heart failure characterized by substantial heterogeneity in left ventricular recovery. Identifying reliable and readily accessible biomarkers associated with myocardial recovery remains an important clinical challenge. Although systemic inflammatory indices such as the systemic immune-inflammation index (SII) have been associated with persistent left ventricular dysfunction in PPCM, they do not incorporate nutritional and immune-related parameters that may also influence clinical outcomes. The Naples Prognostic Score (NAPLES), which integrates inflammatory, immune, and nutritional parameters, has emerged as a promising prognostic index in cardiovascular disease; however, its role in PPCM has not yet been elucidated. In this context, this study aimed to investigate the association between the Naples Prognostic Score and left ventricular functional recovery in patients with peripartum cardiomyopathy, and to compare its discriminatory ability with that of the Systemic Immune-Inflammation Index (SII).
methodsThis retrospective single-center study included 30 patients diagnosed with PPCM between 2015 and 2025. Left ventricular functional recovery was defined as an LVEF ≥ 50% at the last available follow-up assessment, provided that follow-up duration was at least 12 months. Laboratory parameters obtained on the day of hospital admission (baseline) were used to calculate NAPLES and SII. Patients were categorized according to the presence or absence of left ventricular functional recovery. Receiver operating characteristic (ROC) curve analysis and risk stratification based on optimal cut-off values were performed.
resultsSixteen patients (53.3%) achieved left ventricular functional recovery, whereas 14 (46.7%) did not. Patients without left ventricular functional recovery exhibited significantly higher SII values and higher NAPLES scores. SII demonstrated good discriminatory ability for differentiating patients according to left ventricular recovery status (AUC = 0.800), and NAPLES also showed a significant association with left ventricular recovery status (AUC = 0.731). A combined model incorporating both SII and NAPLES yielded the highest numerical AUC (0.818), although no statistically significant improvement compared with SII alone was observed. An SII > 1332 and a NAPLES score ≥ 3 were associated with a significantly increased risk of persistent left ventricular dysfunction.
conclusionsBoth SII and NAPLES were significantly associated with left ventricular functional recovery in patients with peripartum cardiomyopathy. By integrating inflammatory, nutritional, and immune-related parameters, the Naples Prognostic Score may provide complementary biological and clinical information beyond conventional inflammatory indices. These findings suggest that readily available biomarkers such as SII and NAPLES may provide additional clinical information and warrant further investigation in PPCM. However, larger prospective studies are required before their clinical applicability can be established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.